Follow $COMP

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $COMP by email
NEW YORK STOCK EXCHANGE, INC. · COMP
+1.39% · +$0.1600 · Vol 4.4M
Live · updated 14:41:52 ET
Compass Inc

Compass Inc

Real Estate
$11.71
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
COMP
Compass Inc
Mon Aug 24 · last completed session · daily score · 20h old
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

71/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 24 · last completed session · daily score · 20h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is COMP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading COMP catalysts
About Compass Inc
REAL ESTATE AGENTS & MANAGERS (FOR OTHERS)
Listed since
2021
Employees
3K
Country
US

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$11.73
Day high
$11.84
Day low
$11.53
Previous close
$11.55
52W high
$13.58
-13.77% from high
52W low
$6.68
73% of range
Market cap
$8.9B
P/E
153.41×
EPS
$0.2000
Beta
2.69
Shares out
767.6M
Volume
4.4M
0.39× rel vol
Avg volume
11.2M
VWAP
$11.71
Price history computed in-house
1W
-4.80%
1M
+5.78%
3M
+39.74%
1Y
+22.88%
YTD
+10.79%
SMA 50 $11.63 · above
SMA 200 $10.05 · above
52W position 73%

COMP overview

Veridion Score
71
Registered · 2026-08-24
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around COMP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading COMP Form 4 filings
Public disclosures

Congress activity in COMP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for COMP in the cached public ledger.

Federal contracts

COMP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for COMP in this window.
Lobbying spend

COMP lobbying filings, year to date.

Registered lobbying filings matched to Compass Inc.

$1.3M
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Medicare/MedicaidMedicare/Medicaid Health Issues
Filing
$340.0K
ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)

ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)

Apr 20, 2026
Filing
$280.0K
ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)

ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)

Jan 20, 2026
Filing
$270.0K
ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)

ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)

Jul 20, 2026
Loading news for COMP
Analyst ratings
Sovereign unlock shows live analyst consensus for COMP.
Options
Sovereign unlock shows live options positioning for COMP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.